VIRX
Viracta Therapeutics, Inc.
Pharmaceutical PreparationsNon-accelerated filer<br>Smaller reporting company
Total Trades
35
Buys
1
Sells
17
Largest Trade
N/A
Insiders
4
Institutional Funds
1
Inst. Value
N/A
Activist Filings
10
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Chevallard Daniel R. | CFO and COO | SELL | $1K–$15K | 3K | $0.73 | Feb 28, 2024 |
| Chevallard Daniel R. | CFO and COO | EXERCISE | N/A | 7K | — | Feb 28, 2024 |
| Rothera Mark | President and CEO | BUY | $15K–$50K | 100K | $0.49 | Dec 4, 2023 |
| Chevallard Daniel R. | CFO and COO | SELL | $1K–$15K | 4K | $0.50 | Nov 29, 2023 |
| Chevallard Daniel R. | CFO and COO | EXERCISE | N/A | 7K | — | Nov 29, 2023 |
| Chevallard Daniel R. | CFO and COO | EXERCISE | N/A | 7K | — | Aug 29, 2023 |
| Chevallard Daniel R. | CFO and COO | SELL | $1K–$15K | 4K | $1.45 | Aug 29, 2023 |
| Chevallard Daniel R. | CFO and COO | EXERCISE | N/A | 7K | — | May 26, 2023 |
| Chevallard Daniel R. | CFO and COO | SELL | $1K–$15K | 4K | $1.42 | May 26, 2023 |
| Rojkjaer Lisa | Chief Medical Offi… | EXERCISE | N/A | 4K | — | Feb 28, 2023 |
| Rojkjaer Lisa | Chief Medical Offi… | SELL | $1K–$15K | 2K | $1.68 | Feb 28, 2023 |
| Chevallard Daniel R. | CFO and COO | EXERCISE | N/A | 7K | — | Feb 28, 2023 |
| Chevallard Daniel R. | CFO and COO | SELL | $1K–$15K | 4K | $1.68 | Feb 28, 2023 |
| Chevallard Daniel R. | CFO and COO | SELL | $1K–$15K | 4K | $2.72 | Nov 29, 2022 |
| Chevallard Daniel R. | CFO and COO | EXERCISE | N/A | 7K | — | Nov 29, 2022 |
| Rojkjaer Lisa | Chief Medical Offi… | EXERCISE | N/A | 4K | — | Nov 29, 2022 |
| Rojkjaer Lisa | Chief Medical Offi… | SELL | $1K–$15K | 2K | $2.72 | Nov 29, 2022 |
| Rojkjaer Lisa | Chief Medical Offi… | SELL | $1K–$15K | 2K | $4.01 | Aug 30, 2022 |
| Rojkjaer Lisa | Chief Medical Offi… | EXERCISE | N/A | 4K | — | Aug 30, 2022 |
| Chevallard Daniel R. | CFO and COO | EXERCISE | N/A | 7K | — | Aug 30, 2022 |
| Chevallard Daniel R. | CFO and COO | SELL | $1K–$15K | 4K | $4.02 | Aug 30, 2022 |
| ROYSTON IVOR | CEO & President | SELL | $50K–$100K | 13K | $4.01 | Aug 30, 2022 |
| ROYSTON IVOR | CEO & President | EXERCISE | N/A | 25K | — | Aug 30, 2022 |
| ROYSTON IVOR | CEO & President | EXERCISE | N/A | 25K | — | May 27, 2022 |
| ROYSTON IVOR | CEO & President | SELL | $15K–$50K | 13K | $1.90 | May 27, 2022 |
| Rojkjaer Lisa | Chief Medical Offi… | SELL | $1K–$15K | 2K | $1.90 | May 27, 2022 |
| Rojkjaer Lisa | Chief Medical Offi… | EXERCISE | N/A | 4K | — | May 27, 2022 |
| Chevallard Daniel R. | CFO and COO | SELL | $1K–$15K | 4K | $1.90 | May 27, 2022 |
| Chevallard Daniel R. | CFO and COO | EXERCISE | N/A | 7K | — | May 27, 2022 |
| ROYSTON IVOR | CEO & President | SELL | $15K–$50K | 15K | $2.78 | Mar 2, 2022 |
| ROYSTON IVOR | CEO & President | EXERCISE | N/A | 25K | — | Mar 2, 2022 |
| Rojkjaer Lisa | Chief Medical Offi… | SELL | $1K–$15K | 2K | $2.78 | Mar 2, 2022 |
| Rojkjaer Lisa | Chief Medical Offi… | EXERCISE | N/A | 4K | — | Mar 2, 2022 |
| Chevallard Daniel R. | CFO and COO | EXERCISE | N/A | 7K | — | Mar 2, 2022 |
| Chevallard Daniel R. | CFO and COO | SELL | $1K–$15K | 4K | $2.78 | Mar 2, 2022 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Dec 31, 2025 · 1 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Motiv8 Investments LLC | 14 | N/A | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G · Feb 15, 2025
4.3%
848K shares
Biotechnology Value Fund, L.P.
SC 13G/A · Nov 14, 2024
0.0%
0 shares
SC 13G · Feb 14, 2024
6.7%
2.6M shares
Biotechnology Value Fund, L.P.
SC 13G/A · Feb 13, 2023
5.2%
2.0M shares
aMoon Growth Fund Limited Partnership
SC 13D/A · Jan 10, 2023
14.0%
5.4M shares
aMoon Growth Fund Limited Partnership
SC 13D/A · Jan 10, 2023
14.0%
5.4M shares
SC 13G · Jul 8, 2022
1.4%
542K shares
SC 13G/A · Feb 15, 2022
0.7%
256K shares
Biotechnology Value Fund, L.P.
SC 13G/A · Feb 14, 2022
4.9%
1.8M shares
SC 13G · Feb 14, 2022
0.8%
289K shares